The Journal of Immunology, Vol 142, Issue 3 737-743, Copyright © 1989 by American Association of Immunologists

ARTICLES

Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells

R Hirsch, RE Gress, DH Pluznik, M Eckhaus and JA Bluestone
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.

Anti-CD3 mAb are known to be both immunosuppressive and mitogenic to T cells in vitro. However, only immunosuppression has been observed after in vivo administration of these mAb. The present study demonstrates that T cell activation does occur after in vivo administration of anti- CD3 mAb to mice, evidenced by increased IL-2R expression on T cells, CSF secretion, and extra-medullary hematopoiesis in the spleen. These effects required multivalent cross-linking of the mAb, since F(ab')2 fragments failed to induce them. However, the F(ab')2 fragments did induce modulation of CD3/TCR from the surface of T cells, demonstrating that TCR modulation is not sufficient to induce activation. In addition, interaction of the TCR with either intact or F(ab')2 fragments of the mAb led to increased expression of CD8 in vivo, suggesting that the F(ab')2 fragments of anti-CD3 mAb might be capable of inducing a T cell to undergo some, but not all, of the changes involved in reaching a fully activated state. Further study of the activating effects of anti-CD3 mAb might increase the understanding of the mechanisms of in vivo T cell activation and might also be exploited clinically to stimulate T cell function in immunocompromised states and to enhance hematopoiesis in myelodysplastic disorders.

This article has been cited by other articles:

				M. T. Getts, B. S. Kim, and S. D. Miller Differential Outcome of Tolerance Induction in Naive versus Activated Theiler's Virus Epitope-Specific CD8+ Cytotoxic T Cells J. Virol., June 15, 2007; 81(12): 6584 - 6593. [Abstract] [Full Text] [PDF]

				H. Zhang, N. Ameen, J. E. Melvin, and S. Vidyasagar Acute inflammation alters bicarbonate transport in mouse ileum J. Physiol., June 15, 2007; 581(3): 1221 - 1233. [Abstract] [Full Text] [PDF]

				N. Miura, M. Yamamoto, M. Fukutake, N. Ohtake, S. Iizuka, A. Ishige, H. Sasaki, K. Fukuda, T. Yamamoto, and S. Hayakawa Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments Int. Immunol., May 1, 2005; 17(5): 513 - 522. [Abstract] [Full Text] [PDF]

				A. P. Kohm, J. S. Williams, A. L. Bickford, J. S. McMahon, L. Chatenoud, J.-F. Bach, J. A. Bluestone, and S. D. Miller Treatment with Nonmitogenic Anti-CD3 Monoclonal Antibody Induces CD4+ T Cell Unresponsiveness and Functional Reversal of Established Experimental Autoimmune Encephalomyelitis J. Immunol., April 15, 2005; 174(8): 4525 - 4534. [Abstract] [Full Text] [PDF]

				C. Scheffold, M. Kornacker, Y. C. Scheffold, C. H. Contag, and R. S. Negrin Visualization of Effective Tumor Targeting by CD8+ Natural Killer T Cells Redirected with Bispecific Antibody F(ab')2HER2xCD3 Cancer Res., October 15, 2002; 62(20): 5785 - 5791. [Abstract] [Full Text] [PDF]

				T. Dao, M. Exley, W. Z. Mehal, S. M. A. Tahir, S. Snapper, M. Taniguchi, S. P. Balk, and I. N. Crispe Involvement of CD1 in Peripheral Deletion of T Lymphocytes Is Independent of NK T Cells J. Immunol., March 1, 2001; 166(5): 3090 - 3097. [Abstract] [Full Text] [PDF]

				D. A. Vallera, D. W. Kuroki, A. Panoskaltsis-Mortari, D. J. Buchsbaum, B. E. Rogers, and B. R. Blazar Molecular modification of a recombinant anti-CD3epsilon -directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine model Blood, August 1, 2000; 96(3): 1157 - 1165. [Abstract] [Full Text] [PDF]

				E. Schneider, V. Salaün, A. Ben Amor, and M. Dy Hematopoietic Changes Induced by a Single Injection of Anti-CD3 Monoclonal Antibody into Normal Mice Stem Cells, March 1, 1997; 15(2): 154 - 160. [Abstract] [Full Text]

				B. K. Cho, B. A. Schodin, and D. M. Kranz Characterization of a Single-chain Antibody to the beta-Chain of the T Cell Receptor J. Biol. Chem., October 27, 1995; 270(43): 25819 - 25826. [Abstract] [Full Text] [PDF]